AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 272 filers reported holding AVANOS MED INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $548,358 | -19.0% | 27,528 | -19.0% | 0.01% | -30.0% |
| Q1 2024 | $676,701 | +86.6% | 33,988 | +110.2% | 0.01% | +42.9% |
| Q4 2023 | $362,626 | +51.7% | 16,167 | +72.9% | 0.01% | +40.0% |
| Q2 2023 | $239,063 | -39.4% | 9,353 | -29.5% | 0.01% | -50.0% |
| Q1 2023 | $394,501 | -31.7% | 13,265 | -37.9% | 0.01% | -37.5% |
| Q4 2022 | $577,731 | -3.2% | 21,350 | -22.1% | 0.02% | -11.1% |
| Q3 2022 | $597,000 | -15.9% | 27,407 | +5.5% | 0.02% | -21.7% |
| Q2 2022 | $710,000 | -44.7% | 25,973 | -32.3% | 0.02% | -42.5% |
| Q1 2022 | $1,285,000 | +135.8% | 38,362 | +143.9% | 0.04% | +122.2% |
| Q4 2021 | $545,000 | -74.8% | 15,731 | -69.0% | 0.02% | -43.8% |
| Q1 2019 | $2,164,000 | -70.7% | 50,701 | -69.3% | 0.03% | -72.2% |
| Q4 2018 | $7,389,000 | -53.6% | 164,961 | -29.1% | 0.12% | -47.7% |
| Q3 2018 | $15,928,000 | – | 232,529 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,441,913 | $88,812,000 | 4.12% |
| RGM Capital, LLC | 2,157,612 | $78,472,000 | 3.63% |
| Millrace Asset Group, Inc. | 32,253 | $1,173,000 | 0.61% |
| HEARTLAND ADVISORS INC | 240,724 | $8,755,000 | 0.51% |
| Champlain Investment Partners, LLC | 2,607,033 | $94,818,000 | 0.45% |
| Campbell & CO Investment Adviser LLC | 27,200 | $989,000 | 0.41% |
| S.A. Mason LLC | 5,565 | $202,000 | 0.14% |
| XTX Topco Ltd | 8,240 | $300,000 | 0.10% |
| AIGEN INVESTMENT MANAGEMENT, LP | 15,186 | $552,000 | 0.10% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 16,875 | $614,000 | 0.09% |